Search Results 231-240 of 16273 for monoclonal antibody

1. Teclistamab-cqyv (subcutaneous route) - Mayo Clinic

   These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...

2. Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

3. Infliximab-axxq (intravenous route) - Mayo Clinic

   Infliximab-axxq is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

4. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may block tumor growth in ... Prior anti-cancer therapy with a monoclonal antibody (mAb) ≤ 4 weeks prior ...

5. Mayo Clinic Q&A podcast: Tackling the latest COVID-19 topics

   Antibody tests after having a COVID-19 vaccine. Monoclonal antibodies. COVID-19 variants. Side effects, especially after second COVID-19 vaccine ...

6. A Study of Pembrolizumab and Ruxolitinib Phosphate for Treating Patients with Metastatic Stage IV Triple Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) ≤4 weeks prior to ...

7. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. ... 3 half-lives (or 6 weeks) must have elapsed since previous monoclonal ...

8. New frontiers in the treatment of COPD - Mayo Clinic

   "There is now interest in determining if targeted monoclonal antibody treatment could reduce COPD exacerbation, says Dr. Dulohery Scrodin. Mayo Clinic's campus ...

9. Dinutuximab (intravenous route) - Mayo Clinic

   This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

10. Research Projects - Infection and Immunity: Raymund R. Razonable - Mayo Clinic Research

    In addition to our research work on transplant-related infections, our lab also is investigating the impact of antiviral drugs and monoclonal antibodies on the ...